{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:11:44Z","timestamp":1747714304027,"version":"3.40.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clml.2025.01.013","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T08:10:46Z","timestamp":1738138246000},"page":"e424-e434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Multiple Myeloma Care: Implementation of Pharmacist-Led Prescribing of Immunomodulatory Drugs in an Academic Medical Setting"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1534-0062","authenticated-orcid":false,"given":"Amy","family":"Indorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3002-8130","authenticated-orcid":false,"given":"Mary","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-4768","authenticated-orcid":false,"given":"Mark","family":"Jao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace T.","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-3005","authenticated-orcid":false,"given":"Kara I.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Portuguese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2817-5440","authenticated-orcid":false,"given":"Eve M.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clml.2025.01.013_bib0001","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.clml.2025.01.013_bib0002","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2146\/ajhp150770","article-title":"Collaborative practice model for management of pain in patients with cancer","volume":"73","author":"Hammer","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.clml.2025.01.013_bib0003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ajhp\/62.3.274","article-title":"ASHP survey of ambulatory care pharmacy practice in health systems\u20132004","volume":"62","author":"Knapp","year":"2005","journal-title":"Am J Health Syst Pharm"},{"year":"2023","key":"10.1016\/j.clml.2025.01.013_bib0004"},{"year":"2023","key":"10.1016\/j.clml.2025.01.013_bib0005"},{"issue":"2","key":"10.1016\/j.clml.2025.01.013_bib0006","first-page":"293","article-title":"Tolerability and safety of real-world use of pomalidomide in patients with relapsed\/refractory multiple myeloma","volume":"10","author":"Usami","year":"2019","journal-title":"Mol Clin Oncol."},{"key":"10.1016\/j.clml.2025.01.013_bib0007","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1200\/JCO.2020.38.29_suppl.221","article-title":"Oral chemotherapy education: hitting the mark?","volume":"38","author":"Berry","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clml.2025.01.013_bib0008","first-page":"190","article-title":"Pharmacist-run chemotherapy-induced nausea and vomiting management protocol improves patient outcomes and benefits physician workflow","volume":"10","author":"Hughes","year":"2020","journal-title":"JHOP"},{"issue":"11","key":"10.1016\/j.clml.2025.01.013_bib0009","article-title":"Clinical pharmacist prescription review and modification for oral antineoplastic medications at an academic medical center. Abstract for the \u20182023 ASCO Quality Care Sympsoim\u2019","volume":"19","author":"Kayamkcalan","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"11","key":"10.1016\/j.clml.2025.01.013_bib0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ajhp\/zxac038","article-title":"Impact of a pharmacist-led telehealth oral chemotherapy clinic","volume":"79","author":"Mathur","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.clml.2025.01.013_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jac5.1741","article-title":"Cancer patients\u2019 experience with a pharmacist-led oral chemotherapy clinic: a qualitative descriptive study","volume":"6","author":"Hamner","year":"2022","journal-title":"J Am Coll Clin Pharm"},{"issue":"4","key":"10.1016\/j.clml.2025.01.013_bib0012","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1200\/JOP.19.00167","article-title":"Adherence to oral anticancer medications after implementation of an ambulatory adherence program at a large urban academic hospital","volume":"16","author":"Curry","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.clml.2025.01.013_bib0013","unstructured":"Wong K, Nguyen M, Malik Z, Ajewole V. Impact of a pharmacist-led oral chemotherapy medication management (MTM) program in a large academic medical center [online]. 2020. https:\/\/cdn.ymaws.com\/tshp.org\/resource\/resmgr\/r&e_foundation\/posters\/2020\/4584888191753567580_-_Poster.pdf (Accessed 25 Oct, 2024)"},{"issue":"46","key":"10.1016\/j.clml.2025.01.013_bib0014","article-title":"Evaluation of a pharmacist led oral chemotherapy clinic: a pilot program in the gastrointestinal oncology clinic at an academic medical center","volume":"8","author":"Darling","year":"2020","journal-title":"Pharmacy"},{"key":"10.1016\/j.clml.2025.01.013_bib0015","first-page":"CR09","article-title":"Pharmacist-led oral chemotherapy monitoring pilot study and assessment of patient-reported outcomes and adherence. Abstract for the \u2018Hematology Oncology Pharmacist Association","volume":"12","author":"Signorelli","year":"2022","journal-title":"JHOP"},{"issue":"2","key":"10.1016\/j.clml.2025.01.013_bib0016","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0897190020970770","article-title":"Impact of pharmacist-led patient education in an ambulatory cancer center: a pilot quality improvement project","volume":"35","author":"Park","year":"2022","journal-title":"J Pharm Pract"},{"issue":"8","key":"10.1016\/j.clml.2025.01.013_bib0017","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1177\/1078155220905004","article-title":"Expansion of pharmacist practice in oral oncolytic therapy with a collaborative practice agreement","volume":"26","author":"Wright","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.clml.2025.01.013_bib0018","first-page":"23","article-title":"Implementation of a pharmacist-managed interdisciplinary oral chemotherapy program in a community cancer center","volume":"1","author":"Mancini","year":"2011","journal-title":"J Hematol Oncol Pharm"},{"issue":"9","key":"10.1016\/j.clml.2025.01.013_bib0019","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/j.clml.2020.04.012","article-title":"Impact of an oncology clinical pharmacist specialist in an outpatient multiple myeloma clinic","volume":"20","author":"Virani","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"10.1016\/j.clml.2025.01.013_bib0020","first-page":"211","article-title":"Impact of pharmacist-led oral chemotherapy telehealth clinic at a community cancer center using the TAMER model","volume":"13","author":"Tamer","year":"2023","journal-title":"J Hematol Oncol Pharm"},{"issue":"6","key":"10.1016\/j.clml.2025.01.013_bib0021","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1200\/JOP.17.00039","volume":"14","author":"Muluneh","year":"2018","journal-title":"J Oncol Pract"},{"issue":"3","key":"10.1016\/j.clml.2025.01.013_bib0022","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/pharmacy9030130","article-title":"Impact of oncology pharmacists on the knowledge, attitude, and practices of clinicians to enhance patient engagement of self-administered oral oncolytics","volume":"9","author":"Palmer","year":"2021","journal-title":"Pharmacy (Basel)"},{"issue":"10","key":"10.1016\/j.clml.2025.01.013_bib0023","doi-asserted-by":"crossref","first-page":"e1209","DOI":"10.1200\/JOP.19.00418","article-title":"Pharmacist-driven oral oncolytic medication education and consent","volume":"16","author":"Bowles","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10.1016\/j.clml.2025.01.013_bib0024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/10781552211052636","article-title":"Impact of a pharmacist-led hypertension management program for oral chemotherapy in a specialty pharmacy setting","volume":"29","author":"Wang","year":"2023","journal-title":"J Oncol Pharm Pract"},{"issue":"8","key":"10.1016\/j.clml.2025.01.013_bib0025","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1177\/10781552211039501","article-title":"Implementation and outcomes of a pharmacist-led oral chemotherapy clinic at VA Maine Healthcare System","volume":"28","author":"Sargent","year":"2022","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"10.1016\/j.clml.2025.01.013_bib0026","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1200\/JOP.18.00581","volume":"15","author":"Mackler","year":"2019","journal-title":"J Oncol Pract"},{"issue":"8","key":"10.1016\/j.clml.2025.01.013_bib0027","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"10.1016\/j.clml.2025.01.013_bib0028","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/OP.21.00198","article-title":"Predictive modeling for adverse events and risk stratification programs for people receiving cancer treatment","volume":"18","author":"Osterman","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"11","key":"10.1016\/j.clml.2025.01.013_bib0029","article-title":"The state of professional wellbeing and satisfaction among US oncologists. Abstract at 2023 ASCO Quality Care Symposium","volume":"19","author":"Schenkel","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.clml.2025.01.013_bib0030","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1200\/EDBK_320873","article-title":"Creating a blueprint of well-being in oncology: an approach for addressing burnout from ASCO's clinician well-being taskforce","volume":"41","author":"Hlubocky","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"10.1016\/j.clml.2025.01.013_bib0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1331\/154434506775268599","article-title":"The pharmacist as physician extender in Family medicine office practice","volume":"46","author":"Nichol","year":"2006","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.clml.2025.01.013_bib0032","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/13696998.2022.2077550","article-title":"Limitations of standard cost-effectiveness methods for health technology assessment of treatments for rare, chronic diseases: a case study of treatment for cystic fibrosis","volume":"25","author":"Rubin","year":"2022","journal-title":"J Med Econ"},{"issue":"3","key":"10.1016\/j.clml.2025.01.013_bib0033","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2023.7106","article-title":"Key performance indicators and metrics for the implementation of an oral chemotherapy adherence program","volume":"22","author":"Muluneh","year":"2024","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T20:26:29Z","timestamp":1747686389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2152265025000254"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.01.013","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing Multiple Myeloma Care: Implementation of Pharmacist-Led Prescribing of Immunomodulatory Drugs in an Academic Medical Setting","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}